Latest news
Search news stories
Enter a keyword to search news.
SAiGENCI recruit recognised with prestigious award
Professor Jenkins has been appointed as the Program Head for the Tumour Inflammation and Immunotherapy Program at the South ÐÓ°ÉÖ±²¥n ImmunoGENomics Cancer Institute (SAiGENCI), which operates within the ÐÓ°ÉÖ±²¥ of Adelaide’s Faculty of Health and Medical Sciences, and is supported by an alliance with the Central Adelaide Local Health Network (CALHN).
[Read more about SAiGENCI recruit recognised with prestigious award]
Towards the future: improving survivorship for children with brain cancer
Brain cancer is the most common solid tumour of childhood and most lethal type of cancer in ÐÓ°ÉÖ±²¥n children.
[Read more about Towards the future: improving survivorship for children with brain cancer]
Unlocking the mysteries of prostate cancer
The SAiGENCI team is creating a comprehensive data repository and applying machine learning to uncover revolutionary insights for prostate cancer treatment and prevention.
[Read more about Unlocking the mysteries of prostate cancer]
National award recognises leading research into pregnancy complications
Chief Investigator Professor Jose Polo from the ÐÓ°ÉÖ±²¥ of Adelaide received the 2022 National Health and Medical Research Council’s (NHMRC) Fiona Stanley Synergy Grant Award at an evening ceremony in Canberra on Wednesday 29 March.
[Read more about National award recognises leading research into pregnancy complications ]
ENZAMET shows promise as prostate cancer treatment
The results from the clinical trial of ENZAMET, co-chaired by Professor Christopher Sweeney, Director of the South ÐÓ°ÉÖ±²¥n immunoGENomics Cancer Institute (SAiGENCI) that operates within the ÐÓ°ÉÖ±²¥ of Adelaide, have been published today in .
[Read more about ENZAMET shows promise as prostate cancer treatment ]
Top talent to boost cancer research
The search for a tailored treatment for cancerous tumours has been bolstered with the appointment of an internationally recognised expert to the South ÐÓ°ÉÖ±²¥n immunoGENomics Cancer Institute (SAiGENCI).Â
David Beale PhD Supplementary Scholarship in Prostate Cancer Research
The David Beale PhD Supplementary Scholarship in Prostate Cancer Research was established in 2023 from a generous donation to the ÐÓ°ÉÖ±²¥ from David Beale to support outstanding emerging researchers in better understanding the causes and exploring potential treatments and cures for prostate cancer.
[Read more about David Beale PhD Supplementary Scholarship in Prostate Cancer Research]
Dr Shanice Mah awarded Cancer Council Beat Cancer Project Fellowship
Dr Shanice Mah, from SAiGENCI's Hormone Dependent Cancers program, has been awarded an Early Career Research Fellowship through the Cancer Council Beat Cancer Project.
[Read more about Dr Shanice Mah awarded Cancer Council Beat Cancer Project Fellowship]
Placenta research puts spotlight on early weeks of human pregnancy
A ÐÓ°ÉÖ±²¥ of Adelaide-led research project will deliver important new knowledge in the first weeks of human development to help reduce infertility and pregnancy complications.
[Read more about Placenta research puts spotlight on early weeks of human pregnancy ]
Dr Shanice Mah awarded 2022 ÐÓ°ÉÖ±²¥n Federation of ÐÓ°ÉÖ±²¥ Women Postdoctoral Award
Congratulations to SAiGENCI's Dr Shanice Mah who has been awarded one of only two, 2022 ÐÓ°ÉÖ±²¥n Federation of ÐÓ°ÉÖ±²¥ Women Postdoctoral Awards.
![RSS News Feed](/global/images/rss.gif" "RSS News Feed"){kind=small}